why choose us

First received: October 04, 2023

Clinical Trial: Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients

Study Status: Completed

Recruit Status: RECRUITING

Condition: Bariatric Surgery Candidate

Study Type: INTERVENTIONAL


Official Title: Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients

Brief Summary: Liposomal bupivacaine (trade name Exparel) is a local analgesic that is designed to produce more long-term pain control.Bupivacaine, a widely used local analgesic, is stored within liposomes, which break down in soft tissue over time.Typical length of therapeutic effect for standard bupivacaine is up to 6 hours.The liposomal formulation of bupivacaine, however, has a length of therapeutic effect of up to 72 hours.Typical post-operative incisional pain is known to last for several days in most cases and is thought…

Read more